GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Cyclically Adjusted PS Ratio

Kyowa Kirin Co (TSE:4151) Cyclically Adjusted PS Ratio : 3.91 (As of Jun. 06, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Kyowa Kirin Co's current share price is 円2704.00. Kyowa Kirin Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円691.22. Kyowa Kirin Co's Cyclically Adjusted PS Ratio for today is 3.91.

The historical rank and industry rank for Kyowa Kirin Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4151' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.06   Med: 3.84   Max: 6.85
Current: 3.84

During the past years, Kyowa Kirin Co's highest Cyclically Adjusted PS Ratio was 6.85. The lowest was 2.06. And the median was 3.84.

TSE:4151's Cyclically Adjusted PS Ratio is ranked worse than
73.79% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs TSE:4151: 3.84

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kyowa Kirin Co's adjusted revenue per share data for the three months ended in Mar. 2024 was 円196.694. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円691.22 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kyowa Kirin Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Kyowa Kirin Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Cyclically Adjusted PS Ratio Chart

Kyowa Kirin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.01 4.56 5.03 4.60 3.45

Kyowa Kirin Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.38 4.00 3.85 3.45 3.89

Competitive Comparison of Kyowa Kirin Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's Cyclically Adjusted PS Ratio falls into.



Kyowa Kirin Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kyowa Kirin Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2704.00/691.22
=3.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Kyowa Kirin Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=196.694/107.2000*107.2000
=196.694

Current CPI (Mar. 2024) = 107.2000.

Kyowa Kirin Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 138.444 98.000 151.441
201409 140.552 98.500 152.966
201412 172.526 97.900 188.915
201503 163.560 97.900 179.097
201506 163.015 98.400 177.594
201509 171.749 98.500 186.919
201512 166.824 98.100 182.299
201603 161.538 97.900 176.883
201606 156.237 98.100 170.730
201609 152.859 98.000 167.209
201612 164.473 98.400 179.182
201703 166.651 98.100 182.110
201706 156.427 98.500 170.243
201709 153.750 98.800 166.822
201712 168.137 99.400 181.331
201803 122.516 99.200 132.396
201806 126.280 99.200 136.464
201809 117.930 99.900 126.548
201812 137.271 99.700 147.597
201903 141.115 99.700 151.730
201906 140.648 99.800 151.077
201909 137.780 100.100 147.553
201912 151.223 100.500 161.305
202003 143.828 100.300 153.722
202006 149.829 99.900 160.777
202009 141.745 99.900 152.103
202012 156.923 99.300 169.407
202103 150.919 99.900 161.947
202106 156.100 99.500 168.180
202109 165.474 100.100 177.211
202112 182.852 100.100 195.822
202203 163.247 101.100 173.097
202206 181.408 101.800 191.031
202209 183.233 103.100 190.520
202212 213.168 104.100 219.516
202303 173.989 104.400 178.655
202306 196.553 105.200 200.290
202309 198.721 106.200 200.592
202312 253.286 106.800 254.235
202403 196.694 107.200 196.694

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kyowa Kirin Co  (TSE:4151) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kyowa Kirin Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (TSE:4151) Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines